Cite
HARVARD Citation
Correale, P. et al. (2020). Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade. Journal for immunotherapy of cancer. 8 (1), p. . [Online].